
ONCONVTHERAPEUTICS
Share · US68232V8019 · TRAW (LSSI)
1,46 EUR
06.06.2025 23:59
Current Prices from ONCONVTHERAPEUTICS
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
TRAW
|
USD
|
06.06.2025 23:59
|
1,67 USD
| 1,52 USD
+10,23 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 20,66 % | 12,73 % | -41,21 % | -67,54 % | -89,45 % | -99,06 % |
Company Profile for ONCONVTHERAPEUTICS Share
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company develops a Phase Ib/II ISS with rigosertib monotherapy in patients with advanced squamous cell carcinoma associated with recessive dystrophic epidermolysis bullosa; and has a preclinical program comprising IV/oral rigosertib for COVID-19. It has a license agreement with SymBio Pharmaceuticals Limited; license, development, and commercialization agreement with Pint International SA.; and a license and collaboration agreement with HanX Biopharmaceuticals, Inc. for the development, registration, and commercialization of narazaciclib. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
Company Data
Name ONCONVTHERAPEUTICS
Company Onconova Therapeutics, Inc.
Symbol TRAW
Website
https://www.onconova.com
Primary Exchange
Lang & Schwarz

ISIN US68232V8019
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Steven M. Fruchtman M.D.
Market Capitalization 21 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 12 Penns Trail, 18940 Newtown
IPO Date 2013-07-25
Stock Splits
Date | Split |
---|---|
23.09.2024 | 1:25 |
ID Changes
Date | From | To |
---|---|---|
03.04.2024 | ONTX | TRAW |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 0T2.F |
NASDAQ | ONTX |
NASDAQ | TRAW |
More Shares
Investors who ONCONVTHERAPEUTICS hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.